Stéphane Bancel (AP Images, Boston Herald)
Covid-19 roundup: FDA shortens interval for Moderna booster dose to 5 months; Moderna CEO says another booster could be necessary this fall — report
The FDA has shortened the recommended interval between the primary series of Moderna’s Covid-19 vaccine and a booster shot to at least five months for adults.
The news comes days after the agency shortened the time interval between Pfizer and BioNTech’s primary series and booster to five months for children and adults 12 years and older. The FDA has also cleared a third dose of the Pfizer/BioNTech shot for certain kids ages five through 11 who are immunocompromised.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
